首页> 外国专利> Use of core constructs and core constructs in the construction of pharmaceutical molecules

Use of core constructs and core constructs in the construction of pharmaceutical molecules

机译:核心构建体和核心构建体在药物分子构建中的用途

摘要

PROBLEM TO BE SOLVED: To provide a core structure which can be used for constructing a pharmaceutical molecule and, in particular, can be bound to a functional component via click chemistry. A core construct comprising a central core, wherein the central core contains (1) a plurality of lysine (K) residues or (2) (Xaa-K) n sequences, and each of the K residues. It is separated from the next K residue by a packed sequence having glycine and serine residues, the number of K residues is 2 to 15, and in the (Xaa-K) n sequence, Xaa is 2 to 2. A core construct of a PEGylated amino acid having 12 repeating units of ethylene glycol, n being an integer of 2-15. [Selection diagram] None
机译:解决的问题:提供一种核心结构,该结构可用于构建药物分子,尤其是可通过点击化学结合到功能性组件上。包含中心核心的核心构建体,其中中心核心包含(1)多个赖氨酸(K)残基或(2)(Xaa-K)n个序列,以及每个K残基。它通过具有甘氨酸和丝氨酸残基的堆积序列与下一个K残基分开,K残基的数目为2至15,在(Xaa-K)n序列中,Xaa为2至2。具有12个乙二醇重复单元的PEG化氨基酸,n为2-15的整数。 [选择图]无

著录项

  • 公开/公告号JP2020128398A

    专利类型

  • 公开/公告日2020-08-27

    原文格式PDF

  • 申请/专利权人 アカデミア シニカ;

    申请/专利号JP20200079616

  • 申请日2020-04-28

  • 分类号A61K47/62;A61P37/02;A61P37/06;A61P17/06;A61P29;A61P19/02;A61P1/04;A61P35;A61P35/02;A61P19/10;A61K47/65;A61K47/60;A61K45;A61K39/395;C07K17/02;C07K16/18;C12N15/13;

  • 国家 JP

  • 入库时间 2022-08-21 11:37:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号